Cockroach Labs
Cockroach Labs develops CockroachDB, a cloud-native, distributed SQL database for scalable, resilient applications that require high availability and consistency.
Secondary Market Price
How Cockroach Labs Measures Up
To help you manage your Cockroach Labs equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series F
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Cockroach Labs's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Cockroach Labs Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Cockroach Labs's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Cockroach Labs is the company behind CockroachDB, a cloud-native, distributed SQL database designed for enterprises to run applications that require high availability and scalability. The company's products, which include CockroachDB and the database-as-a-service offering CockroachCloud, are used across sectors like finance, gaming, manufacturing, and media for functions such as identity management, logistics, and security compliance. For example, the sports betting company FanDuel uses CockroachDB to manage its financial ledger. Founded in 2015 by Spencer Kimball, Benjamin Darnell, and Peter Mattis, the company is headquartered in New York and has since expanded with offices in Austin, Toronto, Bengaluru, and London.
Recent company activity indicates a focus on supporting artificial intelligence workloads and forming strategic partnerships. Cockroach Labs has announced a partnership with ClickHouse to enable real-time AI applications and another with Ory Corp for scalable authorization and authentication. The company also continues to highlight its integration with major cloud providers like AWS. In a recent announcement, co-founder Spencer Kimball was slated to discuss how AI is influencing data infrastructure requirements. As of January 2022, the company had raised a total of $354.9 million, with its most recent funding being a $278 million Series F round.
- Greenoaks
- Altimeter
- BOND
- Benchmark
- Coatue
- FirstMark
- GV
- Index Ventures
- J.P. Morgan
- Lone Pine Capital
- Redpoint Ventures
- Tiger Global
- Co-Founder, Spencer Kimball
- Co-Founder, Peter Mattis
- Co-Founder, Ben Darnell
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Cockroach Labs worth joining?
Deciding to join a company like Cockroach Labs involves evaluating its growth potential, culture, and the value of its compensation package. Tools like Prospect can help you understand the potential future value of your equity compensation, which is a critical part of the decision.
What should I do with my Cockroach Labs stock?
Managing your private company stock involves making strategic decisions about when to exercise options and sell shares to maximize your after-tax earnings. Prospect offers personalized strategies and tools to help you navigate these choices, from tax optimization to planning for life events.
Can you sell Cockroach Labs stock?
As a private company, Cockroach Labs stock isn't traded on a public exchange, but employees can often sell shares through secondary markets or company-approved tender offers. Prospect provides tender offer tools and access to secondary market data to help you decide when and how much to sell in a tax-efficient way.
How can I find the value of my Cockroach Labs stock?
The value of private stock is typically determined by the company's latest 409A valuation, recent funding rounds, or secondary market transactions. To get a more forward-looking estimate, Prospect uses proprietary predictive models trained on venture capital data to project your equity's future worth.
What is Cockroach Labs's equity worth?
The total worth of your equity depends on the number of shares you hold and the company's current valuation, which can fluctuate between funding rounds. Platforms like Prospect can help you calculate the net value of your holdings by modeling different scenarios and accounting for taxes.
What is Cockroach Labs's stock ticker symbol?
Cockroach Labs is a private company, so it does not have a stock ticker symbol. Ticker symbols are assigned to companies only when they become publicly traded on a stock exchange.
Can I buy or sell Cockroach Labs stock?
Selling private stock is sometimes possible through tender offers or secondary markets, while buying is typically restricted to accredited investors in specific funding rounds. If you are an employee with equity, Prospect can provide guidance on the optimal timing and strategy for selling your shares.
What is the criteria to buy or invest in Cockroach Labs stock?
Investing in a private company like Cockroach Labs is generally limited to institutional investors, venture capital firms, or accredited investors during official funding rounds. For employees who already have equity, platforms like Prospect focus on maximizing the value of those existing shares rather than facilitating new investments.
